Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,735,180
+$1,838,084 QoQ
Shares Held
109,450
-0.7% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#119
of 421 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $170,891,735 across 22 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
128,626 | $69,693,424 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
297,297 | $50,106,435 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
746,855 | $18,380,101 | |
| 4 | ALKS |
Alkermes plc.
This page
|
109,450 | $5,735,180 | |
| 5 | LQDA |
Liquidia Corp
|
46,133 | $3,678,184 | |
| 6 | VTRS |
Viatris Inc
|
230,572 | $3,661,482 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
80,062 | $3,284,943 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
113,125 | $1,958,193 |
All Filings in ALKS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,735,180 | 109,450 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,897,096 | 110,212 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,261,712 | 116,573 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,666,270 | 122,209 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,469,076 | 121,254 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $3,944,007 | 119,443 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $3,596,898 | 125,066 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,619,442 | 129,312 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,385,519 | 140,478 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,708,412 | 210,876 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,911,557 | 357,302 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,953,789 | 248,261 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,062,421 | 353,432 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,024,863 | 249,197 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $6,511,516 | 249,197 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $8,015,688 | 358,965 | Shares | Defined | 2022-11-14 | |
| 2020-06-30 | $1,878,227 | 96,766 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,395,365 | 96,766 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||